US FDA had conducted inspections at the Company's manufacturing facilities located at St. Louis, Fen ton Park, USA from 16th August 2019 to 22nd August, 2019 and Baddi, India from 19th August, 2019 to 23rd August, 2019.
At the end of the inspection, the Company has received a Form 483 with four (4) observations for the facility located at St. Louis, Fenton Park, USA and no Form 483 is received for the facility located at Baddi, India.
The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA Observations for the facility located at St. Louis, Fenton Park, USA and the same is proposed to be filed within the timeline stipulated by US FDA.
Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.1771.3 as compared to the previous close of Rs. 1750.05. The total number of shares traded during the day was 359 in over 149 trades.
The stock hit an intraday high of Rs. 1796 and intraday low of 1757.5. The net turnover during the day was Rs. 637975.